The global pharmaceutical and biotechnology sectors, integral components of the broader healthcare industry, are grappling with a significant environmental paradox:…
Read More

The global pharmaceutical and biotechnology sectors, integral components of the broader healthcare industry, are grappling with a significant environmental paradox:…
Read More
Novartis reported a challenging first quarter for 2026, with profits experiencing a significant downturn primarily due to the intensified impact…
Read More